Skip to Main Content

The pharmaceutical industry may be fighting a first-in-the-nation law in Nevada to demand pricing transparency on diabetes drugs, but Colorado legislator Dylan Roberts is not deterred.

Last week, he introduced a bill to similarly demand that drug makers report pricing histories, explain price hikes, disclose costs, and reveal the rebates paid to pharmacy benefit managers. And as in Nevada, he hopes the legislation will slow the cost of caring for diabetes. In Colorado, about $720 million, or 19 percent, of all diabetes care is spent on prescription drugs to control the disease, according to the bill.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED